REGN Cash & Equivalents
Regeneron Pharmaceuticals · Cash & Equivalents
REGN Cash & Equivalents
Latest reported$3.12Bperiod ending
REGN FY Cash & Equivalents ($21.80M → $3.12B)
Annual Cash & Equivalents
High-resolution chart · PNG
REGN cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 3,118,100,000 | |
| 2,488,200,000 | |
| 2,730,000,000 | |
| 3,105,900,000 | |
| 2,885,600,000 | |
| 2,193,700,000 | |
| 1,617,800,000 | |
| 1,467,700,000 | |
| 812,733,000 | |
| 535,203,000 | |
| 809,102,000 | |
| 648,719,000 | |
| 535,608,000 | |
| 230,276,000 | |
| 483,610,000 | |
| 112,572,000 | |
| 207,075,000 | |
| 247,796,000 | |
| 498,925,000 | |
| 237,876,000 | |
| 184,508,000 | |
| 101,234,000 | |
| 118,285,000 | |
| 80,077,000 | |
| 247,393,000 | |
| 30,978,000 | |
| 23,700,000 | |
| 19,800,000 | |
| 28,900,000 | |
| 34,500,000 | |
| 32,700,000 | |
| 23,600,000 | |
| 12,500,000 | |
| 16,400,000 | |
| 26,200,000 | |
| 21,800,000 |